Krystal Biotech (KRYS) News Today → Crypto Millionaire Says: “Buy This $11 AI Coin.” (From InvestorPlace) (Ad) Free KRYS Stock Alerts $154.82 +0.06 (+0.04%) (As of 05/13/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 13 at 4:46 AM | marketbeat.comRussell Investments Group Ltd. Sells 13,219 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)Russell Investments Group Ltd. reduced its position in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 34.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 25,479 shares of the company's stock after selling 13,21May 11 at 5:29 AM | americanbankingnews.comCantor Fitzgerald Equities Analysts Raise Earnings Estimates for Krystal Biotech, Inc. (NASDAQ:KRYS)May 10, 2024 | marketbeat.comFY2024 EPS Estimates for Krystal Biotech, Inc. Increased by Cantor Fitzgerald (NASDAQ:KRYS)Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) - Equities researchers at Cantor Fitzgerald boosted their FY2024 earnings estimates for shares of Krystal Biotech in a report issued on Tuesday, May 7th. Cantor Fitzgerald analyst J. Schimmer now forecasts that the company will earn $4.00 per sharMay 10, 2024 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) Shares Sold by Victory Capital Management Inc.Victory Capital Management Inc. reduced its holdings in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 17.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 172,879 shares of the company's stock after selling 36,608 shareMay 10, 2024 | americanbankingnews.comWilliam Blair Brokers Lift Earnings Estimates for Krystal Biotech, Inc. (NASDAQ:KRYS)May 9, 2024 | marketbeat.comQ3 2024 EPS Estimates for Krystal Biotech, Inc. Lifted by Analyst (NASDAQ:KRYS)Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) - Investment analysts at William Blair boosted their Q3 2024 EPS estimates for shares of Krystal Biotech in a research note issued to investors on Monday, May 6th. William Blair analyst T. Lugo now expects that the company will earn $0.63 per sharMay 9, 2024 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) Shares Sold by New York State Common Retirement FundNew York State Common Retirement Fund lessened its position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 32.1% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 14,993 shares of the company's stock after sellinMay 9, 2024 | americanbankingnews.comKrystal Biotech, Inc. (NASDAQ:KRYS) Forecasted to Post Q2 2024 Earnings of $0.37 Per ShareMay 9, 2024 | americanbankingnews.comQ2 2024 Earnings Forecast for Krystal Biotech, Inc. Issued By William Blair (NASDAQ:KRYS)May 9, 2024 | marketbeat.comTimesSquare Capital Management LLC Buys 127,435 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)TimesSquare Capital Management LLC grew its stake in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 103.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 250,470 shares of the company's stMay 8, 2024 | globenewswire.comKrystal Biotech to Present at BofA Securities 2024 Health Care ConferenceMay 8, 2024 | marketbeat.comHC Wainwright Brokers Raise Earnings Estimates for Krystal Biotech, Inc. (NASDAQ:KRYS)Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) - Analysts at HC Wainwright upped their Q2 2024 EPS estimates for Krystal Biotech in a report issued on Monday, May 6th. HC Wainwright analyst J. Pantginis now forecasts that the company will post earnings per share of $0.37 for the quarter, up frMay 8, 2024 | americanbankingnews.comKrystal Biotech (NASDAQ:KRYS) Rating Reiterated by HC WainwrightMay 7, 2024 | finance.yahoo.comKrystal Biotech, Inc. (NASDAQ:KRYS) Q1 2024 Earnings Call TranscriptMay 7, 2024 | markets.businessinsider.comMaintaining Buy Rating on Krystal Biotech: Strong VYJUVEK Sales and Promising Pipeline Despite EPS MissMay 7, 2024 | marketbeat.comKrystal Biotech (NASDAQ:KRYS) Announces Quarterly Earnings ResultsKrystal Biotech (NASDAQ:KRYS - Get Free Report) posted its earnings results on Monday. The company reported $0.03 EPS for the quarter, missing the consensus estimate of $0.20 by ($0.17). The company had revenue of $45.25 million during the quarter, compared to analysts' expectations of $47.37 million. Krystal Biotech's revenue for the quarter was up 452400.0% compared to the same quarter last year. During the same quarter in the prior year, the company posted ($1.76) EPS.May 7, 2024 | marketwatch.comKrystal Biotech Shares Drop After 1Q Earnings MissMay 7, 2024 | msn.comKrystal Biotech misses top-line and bottom-line estimates; reaffirms FY24 outlookMay 7, 2024 | finance.yahoo.comKrystal Biotech Inc (KRYS) (Q1 2024) Earnings Call Transcript Highlights: Robust Growth and ...May 7, 2024 | bizjournals.comKrystal Biotech adds to revenue despite challenges in Q1May 6, 2024 | markets.businessinsider.comKrystal Biotech Announces First Quarter 2024 Financial Results and Provides Business UpdatesMay 6, 2024 | finance.yahoo.comKrystal Biotech Inc (KRYS) Surpasses Revenue Estimates in Q1 2024May 6, 2024 | marketbeat.comKrystal Biotech (NASDAQ:KRYS) Shares Gap Down to $161.10Krystal Biotech (NASDAQ:KRYS) Shares Gap Down to $161.10May 6, 2024 | marketbeat.comKrystal Biotech (NASDAQ:KRYS) Earns "Buy" Rating from HC WainwrightHC Wainwright restated a "buy" rating and issued a $200.00 target price on shares of Krystal Biotech in a research note on Monday.May 6, 2024 | investorplace.comKRYS Stock Earnings: Krystal Biotech Beats EPS, Misses Revenue for Q1 2024May 6, 2024 | globenewswire.comKrystal Biotech Announces First Quarter 2024 Financial Results and Provides Business UpdatesMay 4, 2024 | americanbankingnews.comKrystal Biotech (KRYS) to Release Quarterly Earnings on MondayMay 3, 2024 | msn.comKrystal Biotech Q1 2024 Earnings PreviewMay 2, 2024 | globenewswire.comKrystal Biotech to Present at the Association for Research in Vision and Ophthalmology 2024 Annual MeetingApril 26, 2024 | globenewswire.comKrystal Biotech to Report First Quarter 2024 Financial Results on May 6, 2024April 24, 2024 | bizjournals.comBrookings takes closer look at Pitt BioForge, Krystal Biotech success in PittsburghApril 24, 2024 | marketbeat.comHandelsbanken Fonder AB Has $15.28 Million Holdings in Krystal Biotech, Inc. (NASDAQ:KRYS)Handelsbanken Fonder AB increased its stake in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 9.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 123,200 shares of the company's stock after purchasing an adApril 23, 2024 | marketbeat.comJennison Associates LLC Buys 383,495 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)Jennison Associates LLC increased its stake in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 112.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 724,344 shares of the company's stock after purchasinApril 22, 2024 | marketbeat.comKrystal Biotech (NASDAQ:KRYS) Receives Buy Rating from HC WainwrightHC Wainwright reissued a "buy" rating and issued a $200.00 target price on shares of Krystal Biotech in a report on Monday.April 22, 2024 | bizjournals.comKrystal Biotech moves to next step in clinical trialApril 22, 2024 | globenewswire.comKrystal Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of Inhaled KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors of the LungApril 22, 2024 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) Shares Sold by Calamos Advisors LLCCalamos Advisors LLC cut its stake in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 38.8% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 15,705 shares of the company's stock after selling 9,942 shares during the quApril 18, 2024 | msn.comCentury Real Estate raises ₹450 crore from Edelweiss to buy land and pay debtsApril 18, 2024 | marketbeat.comAllspring Global Investments Holdings LLC Has $7.36 Million Holdings in Krystal Biotech, Inc. (NASDAQ:KRYS)Allspring Global Investments Holdings LLC increased its stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 8.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 59,324 shares of the company's stock aftApril 16, 2024 | marketbeat.com6,624 Shares in Krystal Biotech, Inc. (NASDAQ:KRYS) Acquired by HealthInvest Partners ABHealthInvest Partners AB purchased a new stake in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 6,624 shares of the company's stock, valued atApril 16, 2024 | marketbeat.comStifel Nicolaus Reaffirms "Buy" Rating for Krystal Biotech (NASDAQ:KRYS)Stifel Nicolaus restated a "buy" rating and issued a $204.00 target price (up previously from $178.00) on shares of Krystal Biotech in a report on Tuesday.April 15, 2024 | finance.yahoo.comRecent 3.8% pullback isn't enough to hurt long-term Krystal Biotech (NASDAQ:KRYS) shareholders, they're still up 437% over 5 yearsApril 12, 2024 | msn.comKarnataka 2nd PUC Result 2024 DECLARED: How to check Class 12 result at karresults.nic.in, other official websiteApril 12, 2024 | finance.yahoo.comThe Zacks Analyst Blog Highlights Bristol Myers, Moderna, 2seventy bio, Amylyx Pharmaceuticals and Syros PharmaceuticalsApril 4, 2024 | tmcnet.comKrystal Biotech to Present at the American Association for Cancer Research 2024 Annual MeetingApril 4, 2024 | globenewswire.comKrystal Biotech to Present at the American Association for Cancer Research 2024 Annual MeetingApril 1, 2024 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) Receives Consensus Recommendation of "Buy" from BrokeragesKrystal Biotech, Inc. (NASDAQ:KRYS - Get Free Report) has earned a consensus recommendation of "Buy" from the nine brokerages that are covering the company, Marketbeat Ratings reports. Nine equities research analysts have rated the stock with a buy recommendation. The average 1 year price target aMarch 29, 2024 | marketbeat.comVanguard Group Inc. Buys 693,852 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)Vanguard Group Inc. grew its stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 40.7% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,400,142 shares of the company's stock after buying an additMarch 27, 2024 | investorplace.com3 Strong Buy Biotech Stocks to Add to Your Q2 Must-Watch ListMarch 26, 2024 | markets.businessinsider.comAttovia Enhances Clinical and Development Expertise with Appointment of Chief Medical Officer and Clinical and Scientific Advisory Boards Get Krystal Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for KRYS and its competitors with MarketBeat's FREE daily newsletter. Email Address The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet. See how you can invest alongside him KRYS Media Mentions By Week KRYS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KRYS News Sentiment▼0.580.57▲Average Medical News Sentiment KRYS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KRYS Articles This Week▼335▲KRYS Articles Average Week Get Krystal Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for KRYS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CRSP News IMVT News HALO News IOVA News IBRX News SWTX News IMCR News ACLX News EXEL News RVMD News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KRYS) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersGuard Against the Coming Financial UpheavalPorter & CompanyElon’s New Device is About to Shock the WorldInvestorPlaceConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe only AI company you should be looking atBehind the MarketsCharles Payne Demystifies OptionsUnstoppable ProsperityForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressGold ManiaStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Krystal Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
